Skip to main content

DexCom, Inc.

Acquisitions

DexCom Acquisitions

2

Major Deals Covered

What are DexCom's biggest acquisitions?

This page covers 2 major deals from 2017 to 2018, each with its price where disclosed and the reason behind it.

Major deals covered
2
First deal
2017
Most recent
2018
CompanyYearPricePurpose
2018Undisclosed—
2017Undisclosed—
What companies has DexCom bought?
Major acquisitions by DexCom documented here include TypeZero Technologies (2018) and Nudge (2017).
What is DexCom's most recent acquisition?
The most recent DexCom acquisition documented here is TypeZero Technologies, in 2018.

TypeZero Technologies

2018

Nudge

2017

DexCom, Inc.'s Growth & Acquisition Strategy

Expanding high-margin paid membership tiers (My Best Buy Total), accelerating digital retail media network advertising, growing healthcare monitoring tech, and optimizing store formats for faster omnichannel fulfillment.

How DexCom, Inc. Makes Money

Best Buy operates an omnichannel specialty retail and services model. It generates revenue through high-volume product sales (computers, televisions, appliances, smartphones), vendor-funded showroom partnerships (store-within-a-store displays with Apple, Samsung, and Microsoft), paid Geek Squad repairs, and recurring My Best Buy Total subscriptions.

DexCom Acquisitions FAQ

What is Dexcom's general approach to M&A and acquisitions?

Dexcom pursues a disciplined, strategic M&A approach focused on acquiring proprietary technologies, expanding customer distribution reach, and unlocking operational cost synergies rather than pursuing unselective scale.

What were some of the most transformative acquisitions completed by Dexcom?

Transformative transactions in Dexcom's history include pivotal mergers and acquisitions that secured key regional footprints, consolidated core market share, and brought proprietary software intellectual property in-house.

How does Dexcom successfully integrate acquired companies?

Dexcom deploys dedicated integration teams to harmonize core software stacks, align regulatory compliance systems, and unite company cultures while preserving entrepreneurial agility.

Does Dexcom divest non-core corporate assets?

Yes, Dexcom periodically evaluates its corporate portfolio, strategically divesting non-core or non-strategic assets to redeploy capital into high-margin core operational divisions.

Related M&A Histories

Compare corporate acquisition records, deal values, and strategic targets

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.